Shasun Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
- Paid Up Capital ₹ 13.45 Cr
- Company Age 48 Year, 9 Months
- Last Filing with ROC 31 Mar 2015
About Shasun Pharmaceuticals
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
L24117TN1976PLC007122
-
Company No.
007122
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
19 Apr 1976
-
Date of AGM
12 Aug 2015
-
Date of Balance Sheet
31 Mar 2015
-
Listing Status
Listed
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Shasun Pharmaceuticals?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhaya Srisrimal
|
Managing Director | 19-Apr-1976 | Current |
| Subramanian Hariharan | CFO | 01-Apr-2014 | Current |
| Suddapalli Muralikrishna | Company Secretary | 20-Apr-2011 | Current |
Board Members (8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Shankarlal Devendra
|
Whole-Time Director | 19-Oct-2006 | Current |
|
Rangaswamy Sundararajan
|
Director | 30-May-2011 | Current |
|
Narayanaswamy Subramanian
|
Director | 19-Aug-2011 | Current |
|
Arun Karmakar
|
Director | 06-Aug-2014 | Current |
|
Taru Mardia
|
Director | 30-Apr-2015 | Current |
|
Sunny Sharma
|
Director | 29-Mar-2012 | Current |
Financial Performance of Shasun Pharmaceuticals.
Enhance accessibility to Shasun Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shasun Pharmaceuticals?
Unlock access to Shasun Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Shasunmed Life-Sciences Private LimitedAbhaya Srisrimal is a mutual person
-
Medispan LimitedRangaswamy Sundararajan is a mutual person
-
Innvolution Healthcare Private LimitedSunny Sharma is a mutual person
-
Innovation Imaging Technologies Private LimitedSunny Sharma is a mutual person
-
General Optics (Asia) LtdAbhaya Srisrimal is a mutual person
-
Marksans Pharma LimitedSunny Sharma is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shasun Pharmaceuticals?
Shasun Pharmaceuticals has a workforce of 661 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shasun Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shasun Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
